Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
Advanced, recurrent, or metastasized osteosarcomas remain challenging to cure or even alleviate. Therefore, the development of novel therapeutic strategies is urgently needed. Cancer immunotherapy has greatly improved in recent years, with options including adoptive cellular therapy, vaccination, an...
Main Authors: | Zenan Wang, Zhan Wang, Binghao Li, Shengdong Wang, Tao Chen, Zhaoming Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01114/full |
Similar Items
-
T–cell–based immunotherapy for osteosarcoma: challenges and opportunities
by: Zhan Wang, et al.
Published: (2016-09-01) -
Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
by: Zhan Wang, et al.
Published: (2018-06-01) -
Th9 Cell Differentiation and Its Dual Effects in Tumor Development
by: Tao Chen, et al.
Published: (2020-05-01) -
Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates
by: Shengdong Wang, et al.
Published: (2018-02-01) -
Blood-based Biomarkers in the Immune Checkpoint Inhibitor Treatment in
Non-small Cell Lung Cancer
by: Peng WANG, et al.
Published: (2021-07-01)